+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Enteral Syringes Market by Product and Geography - Forecast and Analysis 2019-2023

  • ID: 4856392
  • Report
  • October 2019
  • Region: Global
  • 146 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Amsino International Inc.
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • Cardinal Health Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Enteral Syringes Market: About this market
The enteral syringes market analysis considers sales from both disposable syringes and reusable syringes products. Our study also finds the sales of enteral syringes in Asia, Europe, North America, and ROW. In 2018, the disposable syringes segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of product launches, regulatory updates, and the growing concerns related to infections in patients will play a significant role in the disposable syringes segment to maintain its market position. Also, our global enteral syringes market report looks at factors such as increasing prevalence of critical care conditions, product launches, and increasing M&A activities. However, safety concerns related to enteral feeding, lack of skilled nurses and advanced infrastructure in developing countries, and limited reimbursement for enteral nutrition and presence of substitute products may hamper the growth of the enteral syringes industry over the forecast period.

Global Enteral Syringes Market: Overview

Increasing prevalence of critical care conditions
The prevalence of critical care conditions such as head and neck cancer, preterm births, (LBW) infants, motor neuron disease, multiple sclerosis. stroke, head injury, and psychiatric diseases are increasing globally, which is rising the demand for enteral feeding products. This, in turn, is likely to drive the adoption of enteral syringes. The growing number of head and neck cancer cases is likely to augment the demand for enteral feeding as patients with oral cancer cannot swallow food, which will drive the growth of the global enteral syringes market at a CAGR of over 5% during the forecast period.

Increasing awareness about enteral feeding in critical care conditions
There is an increase in the demand for enteral feeding products due to the increasing incidence of head injuries, multiple sclerosis, head and neck cancer, and preterm births. The increasing prevalence of psychiatric diseases and motor neuron diseases is also driving the adoption of enteral feeding products in healthcare units. Non-profit organizations, such as Feeding Tube Awareness Foundation, and product manufacturers are conducting various campaigns to raise awareness about the safety of enteral feeding in infants and adults. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global enteral syringes market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading enteral syringes manufacturers, that include Amsino International Inc., Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., Cardinal Health Inc., GBUK Group Ltd., Medela AG, Terumo Corp., and Thermo Fisher Scientific Inc.

Also, the enteral syringes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amsino International Inc.
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • Cardinal Health Inc.

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Disposable syringes - Market size and forecast 2018-2023
  • Reusable syringes - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Amsino International Inc.
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Co.
  • Cardinal Health Inc.
  • GBUK Group Ltd.
  • Medela AG
  • Terumo Corp.
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Disposable syringes - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Disposable syringes - Year-over-year growth 2019-2023 (%)
Exhibit 22: Reusable syringes - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Reusable syringes - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Incidence of cancer in US - 2016
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Estimated incidence of larynx cancer in European countries 2018
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Product launch details
Exhibit 41: M&A and their market impact analysis
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Business strategies and market impact
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Amsino International Inc. - Vendor overview
Exhibit 50: Amsino International Inc. - Product segments
Exhibit 51: Amsino International Inc. - Organizational developments
Exhibit 52: Amsino International Inc. - Key offerings
Exhibit 53: Amsino International Inc. - Key customers
Exhibit 54: Avanos Medical Inc. - Vendor overview
Exhibit 55: Avanos Medical Inc. - Product segments
Exhibit 56: Avanos Medical Inc. - Organizational developments
Exhibit 57: Avanos Medical Inc. - Geographic focus
Exhibit 58: Avanos Medical Inc. - Segment focus
Exhibit 59: Avanos Medical Inc. - Key offerings
Exhibit 60: Avanos Medical Inc. - Key customers
Exhibit 61: B. Braun Melsungen AG - Vendor overview
Exhibit 62: B. Braun Melsungen AG - Business segments
Exhibit 63: B. Braun Melsungen AG - Organizational developments
Exhibit 64: B. Braun Melsungen AG - Geographic focus
Exhibit 65: B. Braun Melsungen AG - Segment focus
Exhibit 66: B. Braun Melsungen AG - Key offerings
Exhibit 67: B. Braun Melsungen AG - Key customers
Exhibit 68: Baxter International Inc. - Vendor overview
Exhibit 69: Baxter International Inc. - Business segments
Exhibit 70: Baxter International Inc. - Organizational developments
Exhibit 71: Baxter International Inc. - Geographic focus
Exhibit 72: Baxter International Inc. - Segment focus
Exhibit 73: Baxter International Inc. - Key offerings
Exhibit 74: Baxter International Inc. - Key customers
Exhibit 75: Becton, Dickinson and Co. - Vendor overview
Exhibit 76: Becton, Dickinson and Co. - Business segments
Exhibit 77: Becton, Dickinson and Co. - Organizational developments
Exhibit 78: Becton, Dickinson and Co. - Geographic focus
Exhibit 79: Becton, Dickinson and Co. - Segment focus
Exhibit 80: Becton, Dickinson and Co. - Key offerings
Exhibit 81: Becton, Dickinson and Co. - Key customers
Exhibit 82: Cardinal Health Inc. - Vendor overview
Exhibit 83: Cardinal Health Inc. - Business segments
Exhibit 84: Cardinal Health Inc. - Organizational developments
Exhibit 85: Cardinal Health Inc. - Geographic focus
Exhibit 86: Cardinal Health Inc. - Segment focus
Exhibit 87: Cardinal Health Inc. - Key offerings
Exhibit 88: Cardinal Health Inc. - Key customers
Exhibit 89: GBUK Group Ltd. - Vendor overview
Exhibit 90: GBUK Group Ltd. - Business segments
Exhibit 91: GBUK Group Ltd. - Key offerings
Exhibit 92: GBUK Group Ltd. - Key customers
Exhibit 93: Medela AG - Vendor overview
Exhibit 94: Medela AG - Product segments
Exhibit 95: Medela AG - Organizational developments
Exhibit 96: Medela AG - Key offerings
Exhibit 97: Medela AG - Key customers
Exhibit 98: Terumo Corp. - Vendor overview
Exhibit 99: Terumo Corp. - Business segments
Exhibit 100: Terumo Corp. - Organizational developments
Exhibit 101: Terumo Corp. - Geographic focus
Exhibit 102: Terumo Corp. - Segment focus
Exhibit 103: Terumo Corp. - Key offerings
Exhibit 104: Terumo Corp. - Key customers
Exhibit 105: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 106: Thermo Fisher Scientific Inc. - Business segments
Exhibit 107: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 108: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 109: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 110: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 111: Thermo Fisher Scientific Inc. - Key customers
Exhibit 112: Validation techniques employed for market sizing
Exhibit 113: Definition of market positioning of vendors
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amsino International Inc.
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • Cardinal Health Inc.
The following companies as the key players in the global enteral syringes market: Amsino International Inc., Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., Cardinal Health Inc., GBUK Group Ltd., Medela AG, Terumo Corp., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing awareness about enteral feeding in critical care conditions.”

According to the report, one of the major drivers for this market is the increasing prevalence of critical care conditions.

Further, the report states that one of the major factors hindering the growth of this market is the safety concerns related to enteral feeding.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Amsino International Inc.
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • Dickinson and Co.
  • Cardinal Health Inc.
  • GBUK Group Ltd.
  • Medela AG
  • Terumo Corp.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown